XML 51 R35.htm IDEA: XBRL DOCUMENT
v3.10.0.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) | 12 Months Ended |
--- | --- | ---
Dec. 31, 2018 USD ($) Number | Dec. 31, 2017 USD ($) | Dec. 31, 2016 USD ($) | Jan. 01, 2019 USD ($)
Shelf life of prescription products following product expiration | 24 months |  |  |
Number of operating segments | Number | 1 |  |  |
Federal insurance limits | $ 250,000 |  |  |
Number of issued patents domestic | Number | 21 |  |  |
Number of issued patents foreign | Number | 24 |  |  |
Advertising costs | $ 1,682,746 | $ 448,288 | $ 752,611 |
Customer A [Member] | Accounts Receivable [Member] |  |  |  |
Concentration risk | 42.00% | 27.00% |  |
Customer B [Member] | Accounts Receivable [Member] |  |  |  |
Concentration risk | 24.00% | 23.00% |  |
Customer C [Member] | Accounts Receivable [Member] |  |  |  |
Concentration risk | 13.00% | 22.00% |  |
Customer D [Member] | Accounts Receivable [Member] |  |  |  |
Concentration risk |  | 11.00% |  |
Minimum [Member] |  |  |  |
Return period of unsalable prescription products | 6 months |  |  |
Minimum [Member] | Fixed Assets [Member] |  |  |  |
Useful life of assets | 3 years |  |  |
Minimum [Member] | Software and Software Development Costs [Member] |  |  |  |
Useful life of assets | 5 years |  |  |
Maximum [Member] |  |  |  |
Return period of unsalable prescription products | 12 months |  |  |
Maximum [Member] | Fixed Assets [Member] |  |  |  |
Useful life of assets | 7 years |  |  |
Maximum [Member] | Software and Software Development Costs [Member] |  |  |  |
Useful life of assets | 7 years |  |  |
Maximum [Member] | IMVEXXY R [Member] |  |  |  |
Enrolled patients co-pay for a set number of prescription refills | $ 35 |  |  |
ASU 2018-11, Leases [Member] | Minimum [Member] |  |  |  |
Right of use asset |  |  |  | $ 4,000,000
Lease liability |  |  |  | 4,000,000
ASU 2018-11, Leases [Member] | Maximum [Member] |  |  |  |
Right of use asset |  |  |  | 5,000,000
Lease liability |  |  |  | $ 5,000,000

X
- Definition The maximum amount enrolled patients pay for a set number of presciption refills under the co-pay assistance program. + References No definition available. + Details
Name: | txmd_EnrolledPatientsCopayMaximumForPrescriptionRefills
Namespace Prefix: | txmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of issued patents domestic. + References No definition available. + Details
Name: | txmd_NumberOfIssuedPatentsDomestic
Namespace Prefix: | txmd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of issued patents foreign. + References No definition available. + Details
Name: | txmd_NumberOfIssuedPatentsForeign
Namespace Prefix: | txmd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period the company accepts returns of unsalable prescription products from customers following product expiration. + References No definition available. + Details
Name: | txmd_ReturnPeriodOfUnsalablePrescriptionProducts
Namespace Prefix: | txmd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period shelf life of prescription products from date of manufacture. + References No definition available. + Details
Name: | txmd_ShelfLifeOfPrescriptionProducts
Namespace Prefix: | txmd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 720 -SubTopic 35 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848 + Details
Name: | us-gaap_AdvertisingExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. + References No definition available. + Details
Name: | us-gaap_CashFDICInsuredAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13531-108611 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13537-108611 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. + References No definition available. + Details
Name: | us-gaap_NumberOfReportableSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Present value of lessee's discounted obligation for lease payments from operating lease. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977 + Details
Name: | us-gaap_OperatingLeaseLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of lessee's right to use underlying asset under operating lease. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977 + Details
Name: | us-gaap_OperatingLeaseRightOfUseAsset
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. + References No definition available. + Details
Name: | us-gaap_PropertyPlantAndEquipmentUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk77Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk78Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk79Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk80Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndBuildingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=txmd_ImvexxyTmMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis=us-gaap_NewAccountingPronouncementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |